Search filters

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 19 March 2015
Author/s

author: Veronika Bachanova  Muneer H Abidi  Anna Sureda  Naomi N Hunder  Patrick Stiff  Auayporn Nademanee  Craig H Moskowitz  Dirk Huebner  Edward Agura  John W Sweetenham  Jerzy Hołowiecki  Jan Walewski  Tamás Masszi 

Publication date March 19, 2015
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item